Nifty

:

24008.00

Sensex

:

79454.47

-265.80 (-1.09%)
-880.34 (-1.10%)

Login

Nifty
Sensex

:
:

24008.00
79454.47

-265.80 (-1.09%)
-880.34 (-1.10%)

Biofil Chemicals & Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 524396 | NSE: BIOFILCHEM

Watchlist

NSE BSE

53.69

06-Feb-2025

Open
High
Low
Previous Close

53.31
55.90
53.31
54.13

Volume
Traded Value (lacs)
52 Week High
52 Week Low

11484
6.24
91.87
40.40

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

67.76
112.01
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

68.00
N/A
3.65

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

21.19
6.16
21.40

EBITDA CAGR (%)

10 Years
5 Years
3 Years

1.17
-14.74
-9.22

PAT CAGR (%)

10 Years
5 Years
3 Years

1.87
-10.11
0.47

P:E (Median)

8 Years
5 Years
3 Years

88.17
136.78
146.65

P:BV (Average)

8 Years
5 Years
3 Years

5.87
6.08
5.08

EV:EBITDA (Average)

8 Years
5 Years
3 Years

45.27
64.61
70.31

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 14.19 5.03 182.11% 2.41 17.37 -86.13% 8.44 2.43 247.33% 15.20 13.62 11.60%
Expenses 13.89 4.84 186.98% 2.29 17.13 -86.63% 8.13 2.02 302.48% 15.24 13.21 15.37%
EBITDA 0.31 0.19 63.16% 0.12 0.24 -50.00% 0.31 0.42 -26.19% -0.03 0.41 -
EBIDTM 2.16% 3.84% 5.14% 1.37% 3.66% 17.13% -0.22% 3.00%
Other Income 0.02 0.03 -33.33% 0.02 0.03 -33.33% 0.03 0.03 0.00% 0.41 0.03 1,266.67%
Interest 0.01 0.00 0 0.01 0.01 0.00% 0.01 0.01 0.00% 0.02 0.01 100.00%
Depreciation 0.10 0.11 -9.09% 0.10 0.11 -9.09% 0.10 0.11 -9.09% 0.08 0.11 -27.27%
PBT 0.22 0.11 100.00% 0.03 0.15 -80.00% 0.23 0.32 -28.12% 0.27 0.32 -15.62%
Tax 0.06 0.02 200.00% 0.01 0.03 -66.67% 0.06 0.08 -25.00% 0.03 0.11 -72.73%
PAT 0.16 0.09 77.78% 0.02 0.12 -83.33% 0.17 0.24 -29.17% 0.25 0.21 19.05%
PATM 1.16% 1.87% 0.99% 0.71% 2.00% 10.02% 1.63% 1.53%
EPS 0.10 0.06 66.67% 0.01 0.08 -87.50% 0.10 0.15 -33.33% 0.15 0.13 15.38%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 40.24 40.04 30.04 22.38 35.75 29.69 23.13 12.36 13.45 13.17 5.86 Net Sales Growth 4.66% 33.29% 34.23% -37.40% 20.41% 28.36% 87.14% -8.10% 2.13% 124.74% Cost Of Goods Sold 37.92 37.51 27.42 19.46 32.43 25.31 19.99 9.77 8.51 10.53 3.85 Gross Profit 2.32 2.53 2.61 2.92 3.32 4.38 3.14 2.59 4.94 2.65 2.01 GP Margin 5.78% 6.32% 8.69% 13.05% 9.29% 14.75% 13.58% 20.95% 36.73% 20.12% 34.30% Total Expenditure 39.55 39.22 28.87 21.05 34.15 27.87 22.11 11.42 10.83 12.30 5.13 Power & Fuel Cost - 0.38 0.33 0.30 0.29 0.49 0.37 0.33 0.44 0.37 0.35 % Of Sales - 0.95% 1.10% 1.34% 0.81% 1.65% 1.60% 2.67% 3.27% 2.81% 5.97% Employee Cost - 0.50 0.45 0.79 0.75 0.86 0.89 0.73 0.53 0.48 0.50 % Of Sales - 1.25% 1.50% 3.53% 2.10% 2.90% 3.85% 5.91% 3.94% 3.64% 8.53% Manufacturing Exp. - 0.31 0.16 0.15 0.30 0.55 0.20 0.14 0.47 0.49 0.19 % Of Sales - 0.77% 0.53% 0.67% 0.84% 1.85% 0.86% 1.13% 3.49% 3.72% 3.24% General & Admin Exp. - 0.41 0.41 0.30 0.29 0.24 0.24 0.39 0.48 0.32 0.16 % Of Sales - 1.02% 1.36% 1.34% 0.81% 0.81% 1.04% 3.16% 3.57% 2.43% 2.73% Selling & Distn. Exp. - 0.01 0.02 0.01 0.01 0.38 0.39 0.04 0.31 0.06 0.00 % Of Sales - 0.02% 0.07% 0.04% 0.03% 1.28% 1.69% 0.32% 2.30% 0.46% 0% Miscellaneous Exp. - 0.11 0.08 0.05 0.08 0.03 0.02 0.02 0.09 0.05 0.00 % Of Sales - 0.27% 0.27% 0.22% 0.22% 0.10% 0.09% 0.16% 0.67% 0.38% 1.37% EBITDA 0.71 0.82 1.17 1.33 1.60 1.82 1.02 0.94 2.62 0.87 0.73 EBITDA Margin 1.76% 2.05% 3.89% 5.94% 4.48% 6.13% 4.41% 7.61% 19.48% 6.61% 12.46% Other Income 0.48 0.49 0.10 0.15 0.80 0.17 0.10 0.10 0.14 0.53 0.46 Interest 0.05 0.04 0.04 0.04 0.07 0.12 0.16 0.15 0.16 0.15 0.21 Depreciation 0.38 0.40 0.43 0.43 0.41 0.41 0.37 0.30 0.28 0.26 0.25 PBT 0.75 0.87 0.79 1.01 1.92 1.46 0.60 0.59 2.31 0.98 0.74 Tax 0.16 0.16 0.23 0.32 0.68 0.26 0.12 0.12 0.52 0.20 0.15 Tax Rate 21.33% 18.39% 29.11% 31.68% 35.42% 17.81% 20.00% 20.34% 22.51% 20.41% 20.27% PAT 0.60 0.71 0.56 0.70 1.24 1.21 0.48 0.47 1.79 0.78 0.59 PAT before Minority Interest 0.60 0.71 0.56 0.70 1.24 1.21 0.48 0.47 1.79 0.78 0.59 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.49% 1.77% 1.86% 3.13% 3.47% 4.08% 2.08% 3.80% 13.31% 5.92% 10.07% PAT Growth -9.09% 26.79% -20.00% -43.55% 2.48% 152.08% 2.13% -73.74% 129.49% 32.20% EPS 0.37 0.44 0.34 0.43 0.76 0.74 0.29 0.29 1.10 0.48 0.36

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 18.20 17.30 16.84 16.13 14.88 13.65 13.17 12.70 10.91 8.41 Share Capital 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 Total Reserves 1.93 1.03 0.56 -0.14 -1.39 -2.62 -3.11 -3.58 -5.37 -7.86 Non-Current Liabilities 0.36 0.38 0.40 0.36 0.00 0.00 0.00 0.00 0.00 0.00 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 28.52 13.73 1.49 16.75 27.48 10.56 10.99 9.14 13.23 5.34 Trade Payables 27.55 12.65 0.60 15.85 25.92 8.58 9.14 7.10 11.59 2.11 Other Current Liabilities 0.29 0.32 0.16 0.14 0.12 0.23 0.17 0.12 0.00 0.00 Short Term Borrowings 0.44 0.52 0.46 0.43 1.19 1.64 1.56 1.43 1.37 2.98 Short Term Provisions 0.24 0.23 0.27 0.33 0.25 0.12 0.11 0.50 0.26 0.25 Total Liabilities 47.08 31.41 18.73 33.24 42.36 24.21 24.16 21.84 24.14 13.75 Net Block 8.62 9.00 9.42 9.78 10.09 10.29 9.25 9.16 8.98 9.06 Gross Block 11.65 11.63 11.62 11.55 11.45 11.24 9.83 9.45 11.04 10.85 Accumulated Depreciation 3.03 2.63 2.20 1.77 1.36 0.95 0.58 0.29 2.06 1.79 Non Current Assets 8.68 9.05 9.42 9.78 10.09 10.29 9.25 9.16 8.98 9.06 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.05 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 38.41 22.35 9.31 23.46 32.27 13.92 14.91 12.68 15.16 4.70 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 2.55 1.21 1.29 4.34 1.69 1.19 1.02 0.17 0.10 0.17 Sundry Debtors 33.03 20.50 7.17 17.22 29.71 12.03 12.98 11.46 13.98 3.65 Cash & Bank 2.28 0.04 0.14 0.44 0.26 0.14 0.37 0.31 0.18 0.13 Other Current Assets 0.55 0.10 0.50 1.41 0.62 0.57 0.53 0.74 0.89 0.75 Short Term Loans & Adv. 0.51 0.50 0.21 0.05 0.43 0.44 0.43 0.59 0.89 0.75 Net Current Assets 9.88 8.63 7.82 6.71 4.79 3.36 3.92 3.53 1.93 -0.64 Total Assets 47.09 31.40 18.73 33.24 42.36 24.21 24.16 21.84 24.14 13.76

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 2.39 -0.11 -0.22 1.11 0.89 1.26 0.46 0.71 0.14 0.01 PBT 0.87 0.79 1.01 1.92 1.46 0.60 0.59 2.31 0.98 0.74 Adjustment 0.63 0.38 0.48 0.48 0.56 0.53 0.45 0.45 0.42 0.46 Changes in Working Capital 1.05 -1.05 -1.40 -0.62 -0.87 0.25 -0.07 -1.84 -0.96 -0.84 Cash after chg. in Working capital 2.55 0.12 0.10 1.79 1.15 1.37 0.97 0.91 0.44 0.35 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.15 -0.21 Tax Paid -0.16 -0.23 -0.32 -0.68 -0.25 -0.11 -0.50 -0.20 -0.15 -0.13 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -0.02 -0.01 -0.07 -0.10 -0.21 -1.41 -0.38 -0.48 -0.19 -0.17 Net Fixed Assets -0.02 -0.01 -0.07 -0.10 -0.21 -1.41 -0.38 1.59 -0.19 -0.17 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.07 0.00 0.00 Cash from Financing Activity -0.12 0.02 -0.01 -0.83 -0.57 -0.08 -0.02 -0.11 0.10 0.11 Net Cash Inflow / Outflow 2.25 -0.11 -0.30 0.18 0.12 -0.24 0.06 0.13 0.05 -0.05 Opening Cash & Equivalents 0.04 0.14 0.44 0.26 0.14 0.37 0.31 0.18 0.13 0.18 Closing Cash & Equivalent 2.28 0.04 0.14 0.44 0.26 0.14 0.37 0.31 0.18 0.13

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 11.19 10.63 10.35 9.91 9.15 8.39 8.09 7.80 4.39 2.85 ROA 1.81% 2.24% 2.69% 3.28% 3.63% 1.99% 2.05% 7.81% 4.13% 4.14% ROE 4.00% 3.28% 4.24% 8.01% 8.46% 3.60% 3.64% 18.09% 13.28% 13.47% ROCE 4.97% 4.76% 6.23% 12.18% 10.12% 5.06% 5.13% 21.86% 14.04% 12.97% Fixed Asset Turnover 3.44 2.58 1.93 3.11 2.62 2.19 1.28 1.31 1.20 0.54 Receivable days 244.02 168.17 198.88 239.55 256.53 197.31 360.94 345.20 244.36 241.46 Inventory Days 17.15 15.23 45.97 30.82 17.72 17.48 17.59 3.56 3.64 13.70 Payable days 195.62 88.15 154.25 235.08 223.27 146.68 239.24 317.92 205.27 204.15 Cash Conversion Cycle 65.55 95.25 90.60 35.29 50.98 68.12 139.29 30.84 42.72 51.02 Total Debt/Equity 0.02 0.03 0.03 0.03 0.08 0.12 0.12 0.11 0.19 0.64 Interest Cover 21.85 19.66 26.00 29.18 12.96 4.70 4.86 15.12 7.46 4.51

Top Investors:

starline equifin private limited

ksl and industries limited

kishor himmatsinh jhala

gom industries ltd

Annual Reports:

News Update:

Biofil Chem & Pharma - Quarterly Results
11th Feb 2025, 17:30 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback